Page last updated: 2024-08-24

2,2'-dithiodiethanesulfonic acid and Carcinoma, Transitional Cell

2,2'-dithiodiethanesulfonic acid has been researched along with Carcinoma, Transitional Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bechtel, SA; Bryan, JN; Bryan, ME; Flesner, BK; Grubb, L; Hausheer, F; Henry, CJ; Lattimer, JC; Selting, KA; Tate, DJ1
Habs, M; Schmähl, D; Tacchi, AM1

Other Studies

2 other study(ies) available for 2,2'-dithiodiethanesulfonic acid and Carcinoma, Transitional Cell

ArticleYear
Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
    Journal of veterinary internal medicine, 2018, Volume: 32, Issue:1

    Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Carcinoma, Transitional Cell; Cisplatin; Creatinine; Diuresis; Dog Diseases; Dogs; Drug Therapy, Combination; Mesna; Piroxicam; Prospective Studies; Renal Insufficiency; Treatment Outcome; Urinary Bladder Neoplasms

2018
[Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
    Der Urologe. Ausg. A, 1984, Volume: 23, Issue:5

    Topics: Animals; Carcinoma, Transitional Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Male; Mercaptoethanol; Mesna; Papilloma; Rats; Rats, Inbred Strains; Urinary Bladder Neoplasms

1984